International Journal of Molecular Sciences Review Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy Peihong Su 1,2,3,† ID , Ye Tian 1,2,3,†, Chaofei Yang 1,2,3, Xiaoli Ma 1,2,3, Xue Wang 1,2,3, Jiawei Pei 1,2,3 and Airong Qian 1,2,3,* ID 1 Lab for Bone Metabolism, Key Lab for Space Biosciences and Biotechnology, School of Life Sciences, Northwestern Polytechnical University, Xi’an 710072, China;
[email protected] (P.S.);
[email protected] (Y.T.);
[email protected] (C.Y.);
[email protected] (X.M.);
[email protected] (X.W.);
[email protected] (J.P.) 2 Research Center for Special Medicine and Health Systems Engineering, School of Life Sciences, Northwestern Polytechnical University, Xi’an 710072, China 3 NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Sciences, Northwestern Polytechnical University, Xi’an 710072, China * Correspondence:
[email protected]; Tel.: +86-29-8849-1840 † These authors contribute equally to this work. Received: 5 June 2018; Accepted: 6 August 2018; Published: 9 August 2018 Abstract: During bone modeling, remodeling, and bone fracture repair, mesenchymal stem cells (MSCs) differentiate into chondrocyte or osteoblast to comply bone formation and regeneration. As multipotent stem cells, MSCs were used to treat bone diseases during the past several decades. However, most of these implications just focused on promoting MSC differentiation. Furthermore, cell migration is also a key issue for bone formation and bone diseases treatment. Abnormal MSC migration could cause different kinds of bone diseases, including osteoporosis.